Valuation: Danaher Corporation

Market Cap 135B 118B 109B 101B 191B 12,878B 195B 1,304B 511B 6,333B 507B 496B 21,923B P/E 2026 *
30.9x
P/E 2027 * 25.5x
Enterprise Value 135B 118B 109B 101B 191B 12,878B 195B 1,304B 511B 6,333B 507B 496B 21,923B EV / Sales 2026 *
5.2x
EV / Sales 2027 * 4.8x
Free-Float
71.14%
Yield 2026 *
0.75%
Yield 2027 * 0.81%
1 day+2.73%
1 week+1.17%
Current month+2.89%
1 month+6.78%
3 months-0.11%
6 months-16.60%
Current year-14.39%
1 week 189.78
Extreme 189.78
197.88
1 month 174.22
Extreme 174.2162
198.23
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 31/08/2020
Director of Finance/CFO - 27/02/2026
Chief Tech/Sci/R&D Officer - 24/08/2025
Director TitleAgeSince
Director/Board Member 74 30/06/1999
Chairman 74 31/12/1983
Director/Board Member 69 31/12/1983
Date Insider Type Main position Quantity % Market Cap.
05-14Free

Director

2,379 0.0003%
05-14Free

Director

2,379 0.0003%
05-14Free

Director

2,379 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+2.73%+1.17%-2.34%-15.92% 135B
+2.86%+2.22%+23.12%+2.14% 190B
-0.86%+2.28%-21.95%+24.23% 147B
+0.40%+4.48%-56.07%-13.96% 66.6B
-2.47%-0.72%+19.56%+1.19% 53.92B
+0.38%-0.29%-26.71%-30.66% 43.57B
+3.50%+0.15%+10.40%+14.18% 36.45B
+2.44%-0.26%+8.44%+42.77% 36.15B
+1.27%+3.65%-18.76%-3.41% 29.69B
+0.03%-0.25%-13.96%-18.74% 29.42B
Average +1.03%+1.06%-7.83%+0.18% 76.74B
Weighted average by Cap. +1.24%+1.55%-4.28%+1.34%

Financials

2026 *2027 *
Net sales 25.95B 22.71B 20.92B 19.37B 36.76B 2,475B 37.41B 251B 98.25B 1,217B 97.42B 95.31B 4,213B 28.14B 24.62B 22.68B 21B 39.86B 2,684B 40.56B 272B 107B 1,320B 106B 103B 4,568B
Net income 4.42B 3.86B 3.56B 3.3B 6.26B 421B 6.37B 42.64B 16.72B 207B 16.58B 16.22B 717B 5.35B 4.68B 4.31B 3.99B 7.58B 510B 7.71B 51.63B 20.25B 251B 20.08B 19.64B 868B
Net Debt - -
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
09/07/26 US$195.98 +2.73% 2,640,532
08/07/26 US$190.77 -1.76% 2,502,661
07/07/26 US$194.19 +0.29% 3,248,899
06/07/26 US$193.62 -2.18% 4,663,821
02/07/26 US$197.93 +2.17% 4,035,515
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
190.77USD
Average target price
242.26USD
Spread / Average Target
+26.99%

Quarterly revenue - Rate of surprise